⚠️ Disclaimer

Retatrutide is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.

Retatrutide is typically reconstituted with bacteriostatic water (BAC water). The standard dosage of 4-12 mg weekly (maintenance after titration) is administered once weekly via subcutaneous injection. Use our peptide calculator for exact mixing ratios.

How Do You Reconstitute Retatrutide?

Retatrutide is supplied as a lyophilized (freeze-dried) powder that must be reconstituted before use. Proper reconstitution is critical for accurate dosing and maintaining stability.

This guide covers the step-by-step process for mixing Retatrutide with bacteriostatic water to achieve your target concentration.

What Supplies Do You Need?

To reconstitute Retatrutide, you need: the Retatrutide vial (lyophilized powder), bacteriostatic water (BAC water with 0.9% benzyl alcohol), insulin syringes (typically 1mL/100-unit), alcohol swabs, and a clean workspace.

Important: Always use bacteriostatic water — not sterile water or saline. BAC water's benzyl alcohol prevents bacterial contamination, extending the usable life of reconstituted Retatrutide to 4-6 weeks.

Step-by-Step Retatrutide Reconstitution

Step 1: Clean the vial tops of both the Retatrutide and BAC water with alcohol swabs.

Step 2: Draw the calculated amount of BAC water into an insulin syringe. Use our peptide calculator to determine the exact amount.

Step 3: Insert the needle into the Retatrutide vial at an angle, and let the water run down the side of the glass — never spray directly onto the powder as this can damage the peptide bonds.

Step 4: Gently swirl (do not shake) the vial until the powder is fully dissolved. The solution should be clear.

Step 5: Label the vial with the date and concentration. Store at 2-8°C.

Calculate Your Retatrutide Dose

Use our free peptide dosing calculator to get exact reconstitution math and syringe units for Retatrutide.

Open Calculator →

How Do You Dose Reconstituted Retatrutide?

After reconstitution, the standard Retatrutide dose is 4-12 mg weekly (maintenance after titration) administered once weekly via subcutaneous injection. The number of units on your insulin syringe depends on how much BAC water you added.

Our calculator will tell you exactly how many units to draw for your dose based on your specific reconstitution ratio.

How Do You Store Reconstituted Retatrutide?

Store reconstituted Retatrutide at 2-8°C (standard refrigerator temperature). Use within 4-6 weeks. Keep away from light and temperature fluctuations.

Unreconstituted Retatrutide powder can be stored at -20°C for 12+ months. Once you reconstitute it, the clock starts.

Bottom Line

Reconstituting Retatrutide is straightforward — add BAC water, swirl gently, refrigerate. The key is using the right amount of water for accurate dosing. Use our peptide calculator every time.

Complete Guide

Retatrutide : Benefits, Dosage, Side Effects & Research

Read the Full Guide →

Related Reading

Research-Grade Sourcing

If you're going to research Retatrutide, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.

Particle → Browse Retatrutide

Frequently Asked Questions

What is Retatrutide?

Retatrutide (Retatrutide (LY3437943)) is a Triple hormone receptor agonist. Novel synthetic peptide developed by Eli Lilly targeting GIP, GLP-1, AND glucagon receptors simultaneously. It is researched for substantial weight loss (up to 24.2%), improved glycemic control, improved liver steatosis, reduced diabetic kidney disease markers.

What is the recommended Retatrutide dosage?

Common dosages: 4-12 mg weekly (maintenance after titration) administered once weekly via subcutaneous injection. Cycle length: 48+ weeks (continuous therapy in trials). Half-life: approximately 4-5 days. Use our peptide calculator for exact reconstitution math.

What are the side effects of Retatrutide?

Gastrointestinal effects predominate: diarrhea, vomiting, constipation, nausea. Generally manageable and dose-dependent. Potential pancreatitis risk similar to GLP-1 agonists.

Is Retatrutide safe?

Retatrutide has shown a preliminary safety profile in research. Not FDA-approved as of March 2026. NDA filing expected late 2026-early 2027. All research should follow appropriate safety protocols.